首页|Incidence,Risk Factors,and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases

Incidence,Risk Factors,and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Objective:Brain metastases significantly impact the clinical course of patients with hepatocellular carcinoma(HCC).This study aimed to examine the age-related incidence,demographics,and survival of patients with HCC and brain metastases.Methods:Data of HCC patients from 2010 to 2015 in the Surveillance,Epidemiology,and End Results(SEER)Registry were screened for the presence of brain metastases.They were stratified by age and ethnicity.Multivariable logistic and Cox regression analyses were used to identify factors associated with brain metastases and those with overall survival(OS)and liver cancer-specific survival(CSS),respectively.Results:A total of 141 HCC patients presenting with brain metastases were identified,accounting for 0.35％of all HCC patients and 2.37％of patients with metastatic disease.Among all HCC patients,the incidence rate was the highest among patients aged 30-49 years old(0.47％).Ethnicity was not associated with the presence of brain metastases at the time of HCC diagnosis.However,African-American patients presented with a significantly lower disease-specific survival[median time:1 month;interquartile range(IQR):0-3.0 months)].Initial lung or bone metastasis was independently associated with an increased risk of the presence of brain metastases[odds ratio(OR):12.62,95％confidence interval(CI):8.40-18.97]but was not associated with a worse OS or CSS among those with brain metastases.Conclusion:This study identified the age-related incidence and risk factors of brain metastases in HCC patients.These results may contribute to the consideration of brain screening among patients with initial metastatic HCC with lung or bone metastases,and influence the counseling of this patient population regarding their prognosis.

brain metastaseshepatocellular carcinomaage-related incidencecancer-specifiic survivaloverall survival

Jin-cheng FENG、Ying HE、Georgios Polychronidis、Jian XIN、Shen YOU、Jun XIONG

展开 >

Department of Liver Transplantation,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China

Key Laboratory of Transplant Engineering and Immunology,Laboratory of Liver Transplantation,Frontiers Science Center for Disease-Related Molecular Network,West China Hospital,Sichuan University,Chengdu 610041,China

Department of General,Visceral and Transplant Surgery,University of Heidelberg,Im Neuenheimer Feld 110,Heidelberg 69120,Germany

Department of Hepatobiliary and Pancreatic Surgery,Fujian Provincial Hospital,Fuzhou 350001,China

展开 >

2024

10.1007/s11596-023-2809-3

当代医学科学(英文)
华中科技大学同济医学院

当代医学科学(英文)

影响因子：0.748
ISSN：2096-5230
年,卷(期)：2024.44(1)
  • 26